Page 1 of 1Results 1 to 7 of 7, 01 - 28 July 2025
-
51cg launches new spin-out Brigid Bio
The 51cg today announces the launch of a new spin-out company developing novel immunotherapies to combat invasive fungal infections.
-
GLP1 weight loss injections may reduce asthma symptoms
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the 51cg and The Observational and Pragmatic Research Institute (OPRI), Singapore.
-
First student entrepreneurship Accelerator programme takes off
The 51cg has successfully completed its inaugural flagship student entrepreneurship programme, the Take Off Accelerator 2025, marking another milestone in its commitment to nurturing the next generation of innovators and changemakers.
-
New study investigates miscarriage prevention guidance
Researchers from the Universities of Aberdeen and Edinburgh are looking into the use of progesterone for early pregnancy bleeding in Scotland.
-
People in poorer areas face lower stroke survival odds
People who have a stroke are more likely to die within a year if they live in more deprived areas according to new research from the 51cg.
-
Covid-19 pandemic had bigger impact on women's health than men's
The Covid-19 pandemic affected women's mental and physical health more than men's, according to research from the 51cg.
-
Diet diversity: average Brit eats at least 49 different species a week
A major study of UK dietary habits has found that the food we eat contains an average of at least 49 different species each week.